Anaemia in heart failure: its diagnosis and management

[1]  K. Swedberg,et al.  Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology , 2002, European journal of heart failure.

[2]  P. Parfrey.  Anaemia in chronic renal disease: lessons learned since Seville 1994. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[4]  D. Farmakis,et al.  Cardiac involvement in thalassemia intermedia: a multicenter study. , 2001, Blood.

[5]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[6]  M. Wallander,et al.  Incidence of newly diagnosed heart failure in UK general practice , 2001, European journal of heart failure.

[7]  G. Sandhagen.  Erythropoetin treatment can increase 2,3-diphosphoglycerate levels in red blood cells , 2001, Scandinavian journal of clinical and laboratory investigation.

[8]  G. Birgegard,et al.  Erythropoetin treatment can increase 2,3-diphosphoglycerate levels in red blood cells , 2001, Scandinavian journal of clinical and laboratory investigation.

[9]  A. Kausz,et al.  Anemia management in patients with chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  A. Levin,et al.  Cardiovascular disease in chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  G. London,et al.  Pathophysiology of anaemia: focus on the heart and blood vessels. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  I. Macdougall,et al.  Novel erythropoiesis stimulating protein. , 2000, Seminars in nephrology.

[13]  Joanne Eastaugh,et al.  The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe , 2000, European journal of heart failure.

[14]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[15]  B. Bourgeon,et al.  High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  K. Wasserman,et al.  Oxygen transport to muscle during exercise in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[17]  U. Grouven,et al.  Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  M. Petch,et al.  The effect of beta2adrenergic blockade on serum potassium and glucose levels during open heart surger , 1981 .

[19]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.